Pharmaceutical giant, Square Pharmaceuticals has seen 14 per cent year-on-year revenue growth for the third (January-March) quarter of the ongoing fiscal year.
Its earnings per share (EPS) rose from Tk4.36 in the same quarter a year ago to Tk5.15 for the third (January-March) quarter of the ongoing fiscal year.
In the first nine months of the current fiscal year, its EPS rose from Tk13.12 a year ago to Tk16.03 rising by more than 22 per cent. Its gross revenue rose from Tk4,387 crores a year ago to over Tk5,000 crores for the first nine months.
Source for more details:
